Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Gerben M. Franssen
In Vitro and in Vivo Characterization of a 18f-AlF-Labeled PSMA Ligand for Imaging of PSMA-expressing Xenografts
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
ImmunoPET Imaging of Renal Cell Carcinoma With124I- And89Zr-Labeled Anti-Caix Monoclonal Antibody cG250 in Mice
Cancer Biotherapy and Radiopharmaceuticals
Nuclear Medicine
Radiology
Pharmacology
Cancer Research
Oncology
Imaging
Medicine
Related publications
First 18f-Labeled Ligand for PET Imaging of uPAR: In Vivo Studies in Human Prostate Cancer Xenografts
Nuclear Medicine and Biology
Cancer Research
Nuclear Medicine
Radiology
Molecular Medicine
Imaging
Comparison of [18F]DCFPyL and [68Ga]Ga-Psma-Hbed-Cc for PSMA-PET Imaging in Patients With Relapsed Prostate Cancer
Molecular Imaging and Biology
Cancer Research
Nuclear Medicine
Radiology
Imaging
Oncology
Discovery of [18f]psma-7, a Novel PET-probe for the Detection of Small PSMA Positive Lesions
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
In Vitro and in Vivo Evaluation of a 18f-Labeled High Affinity NOTA Conjugated Bombesin Antagonist as a PET Ligand for GRPR-Targeted Tumor Imaging
PLoS ONE
Multidisciplinary
Low Level Endogenous Prostate-Specific Membrane Antigen (PSMA) Expression in Non-Prostatic Tumor Xenografts Is Sufficient for in Vivo Tumor Targeting and Imaging
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
In Vivo and in Vitro Characterization of a Novel MAO-B Inhibitor Radioligand, 18f-Labeled Deuterated Fluorodeprenyl
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Optimization of PET Protocol and Interrater Reliability of 18f-Psma-11 Imaging of Prostate Cancer
EJNMMI Research
Nuclear Medicine
Radiology
Imaging
64Cu-Psma-617: A Novel PSMA-targeted Radio-Tracer for PET Imaging in Gastric Adenocarcinoma Xenografted Mice Model
Oncotarget
Oncology
Full Preclinical Validation of the 123i-Labeled Anti-Psma Antibody Fragment ScFvD2B for Prostate Cancer Imaging
Oncotarget
Oncology